Additives in neuraxial anesthesia: opioids, alpha-2 adrenergic agonists, and neostigmine as a possible future drug for perioperative pain management

Acta Anaesthesiol Scand Suppl. 1996:109:176-8.

Authors

W Klimscha¹, A Chiari, C Lorber, K Krenn, R Dumitrescu, T Agnese

Affiliation

¹ Department of Anesthesia and General Intensive Care A, University of Vienna, Austria.

PMID: 8901999

No abstract available

MeSH terms

Adjuvants, Anesthesia / administration & dosage*
Adrenergic alpha-2 Receptor Agonists
Adrenergic alpha-Agonists / administration & dosage
Adrenergic alpha-Agonists / therapeutic use*
Analgesia, Epidural*
Analgesics, Opioid / administration & dosage
Analgesics, Opioid / therapeutic use*
Anesthesia, Epidural*
Cholinesterase Inhibitors / administration & dosage
Cholinesterase Inhibitors / therapeutic use*
Drug Interactions
Drug Synergism
Humans
Injections, Spinal
Neostigmine / administration & dosage
Neostigmine / therapeutic use*
Nociceptors / drug effects
Pain, Postoperative / prevention & control*

Substances

Adjuvants, Anesthesia
Adrenergic alpha-2 Receptor Agonists
Adrenergic alpha-Agonists
Analgesics, Opioid
Cholinesterase Inhibitors
Neostigmine